What is the pandemic potential of avian influenza A(H5N1)?
On March 25, 2024, a national authority in Viet Nam notified WHO of a case of human infection with highly pathogenic avian influenza. Then on April 1, a second but unrelated human infection with (H5N1virus was reported in Texas, USA.
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Safe and effective vaccines against SARS-CoV-2 were developed in less than 1 year.
Wastewater testing finds H5N1 avian flu in 9 Texas cities
Researchers who sequenced viruses from wastewater samples from 10 Texas cities found H5N1 avian flu virus in 9 of them, sometimes at levels that rivaled seasonal flu.
Consensus sequences for U.S. H5N1 clade 2.3.4.4b (GISAID)
Defining the balance between optimal immunity and immunopathology in influenza virus infection
Influenza A viruses remain a global threat to human health, with continued pandemic potential.
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
It is well-established that older adults are at increased risk of severe and fatal COVID-19, but the mechanisms underlying this susceptibility are not entirely clear.
Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review
Diabetes affects millions of people worldwide, making them more vulnerable to infections, including seasonal influenza. It is therefore particularly important for those suffering from diabetes to be vaccinated against influenza each year.
Highly Pathogenic Avian Influenza A (H5N1) clade 2.3.4.4b Virus detected in dairy cattle
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies
Streptococcus pyogenes can cause invasive disease with high mortality despite adequate antibiotic treatments. To address this unmet need, we have previously generated an opsonic IgG1 monoclonal antibody, Ab25, targeting the bacterial M protein.
News
Scientific Papers
Article
Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway
tudy using data from more than 20 million participants has shown that COVID-19 vaccines consistently prevent long COVID symptoms in adults
Study on the clinical efficacy and safety of baloxavir marboxil tablets in the treatment of influenza A